Search details
1.
The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells.
Biotechnol Appl Biochem
; 65(3): 407-418, 2018 May.
Article
in English
| MEDLINE | ID: mdl-28981962
2.
Antagonistic TSC22D1 variants control BRAF(E600)-induced senescence.
EMBO J
; 30(9): 1753-65, 2011 May 04.
Article
in English
| MEDLINE | ID: mdl-21448135
3.
Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.
Stem Cells
; 30(6): 1076-86, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22438320
4.
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
Prostate
; 72(15): 1678-87, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22473923
5.
In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
Prostate
; 69(15): 1683-93, 2009 Nov 01.
Article
in English
| MEDLINE | ID: mdl-19644960
6.
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Cancer Res
; 67(18): 8742-51, 2007 Sep 15.
Article
in English
| MEDLINE | ID: mdl-17875715
7.
Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.
Mol Cancer Res
; 17(5): 1049-1062, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30745464
8.
Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
Prostate
; 68(12): 1307-18, 2008 Sep 01.
Article
in English
| MEDLINE | ID: mdl-18512728
9.
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma.
Oncotarget
; 9(48): 28877-28896, 2018 Jun 22.
Article
in English
| MEDLINE | ID: mdl-29988965
10.
Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo.
Cancer Res
; 65(17): 7682-90, 2005 Sep 01.
Article
in English
| MEDLINE | ID: mdl-16140935
11.
Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice.
J Bone Miner Res
; 17(6): 998-1007, 2002 Jun.
Article
in English
| MEDLINE | ID: mdl-12054176
12.
Peptabodies as tools to test ligands isolated from phage-displayed peptide libraries.
J Immunol Methods
; 276(1-2): 135-41, 2003 May 01.
Article
in English
| MEDLINE | ID: mdl-12738366
13.
Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries.
J Immunol Methods
; 264(1-2): 173-86, 2002 Jun 01.
Article
in English
| MEDLINE | ID: mdl-12191520
14.
Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer.
PLoS One
; 9(4): e94922, 2014.
Article
in English
| MEDLINE | ID: mdl-24740307
15.
The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
PLoS One
; 9(12): e114530, 2014.
Article
in English
| MEDLINE | ID: mdl-25485970
16.
Characterization and clinical relevance of ALDHbright populations in prostate cancer.
Clin Cancer Res
; 19(19): 5361-71, 2013 Oct 01.
Article
in English
| MEDLINE | ID: mdl-23969936
17.
Circulating fibronectin controls tumor growth.
Neoplasia
; 15(8): 925-38, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23908593
18.
Diagnostic microchip to assay 3D colony-growth potential of captured circulating tumor cells.
Lab Chip
; 12(13): 2313-6, 2012 Jul 07.
Article
in English
| MEDLINE | ID: mdl-22565166
19.
Occlusion of seminal vesicles increases sexual activity in a mouse model.
Eur Urol
; 62(5): 855-62, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22552215
20.
The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis.
PLoS One
; 6(1): e16078, 2011 Jan 13.
Article
in English
| MEDLINE | ID: mdl-21249149